Valuation: Immunocore Holdings plc

Market Cap 1.64B 1.42B 1.34B 1.22B 2.28B 157B 2.29B 16B 6.18B 79.62B 6.15B 6.01B 254B P/E 2026 *
-629x
P/E 2027 * -79.2x
Enterprise Value 1.38B 1.19B 1.13B 1.02B 1.92B 132B 1.93B 13.46B 5.2B 66.96B 5.17B 5.05B 213B EV / Sales 2026 *
3.05x
EV / Sales 2027 * 2.68x
Free-Float
89.5%
Yield 2026 *
-
Yield 2027 * -
1 day-0.58%
1 week-8.36%
Current month-13.02%
1 month-9.87%
3 months+12.14%
6 months+3.34%
Current year-8.99%
1 week 31.14
Extreme 31.135
34.38
1 month 31.14
Extreme 31.135
37.95
Current year 27.56
Extreme 27.555
37.95
1 year 27.56
Extreme 27.555
40.71
3 years 23.15
Extreme 23.15
76.98
5 years 18.43
Extreme 18.43
76.98
10 years 18.43
Extreme 18.43
76.98
Manager TitleAgeSince
Chief Executive Officer 65 2018-12-31
Director of Finance/CFO 45 2024-12-31
Compliance Officer 59 2023-12-31
Director TitleAgeSince
Director/Board Member 65 2019-02-05
Chairman 74 -
Director/Board Member 66 2017-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
5/27/26 Free

Director

27,492 0.0546%
5/27/26 Free

Director

27,492 0.0546%
5/27/26 Free

Chairman

27,492 0.0546%
Change 5-day change 1-year change 3-year change Capi.($)
-0.58%-8.36%-6.55%-39.00% 1.64B
+0.24%+1.30%+48.92%+99.34% 1,013B
+0.03%+0.07%+51.47%+64.51% 644B
-0.17%+4.65%+21.42%+70.57% 465B
+0.53%+3.42%+39.21%+38.70% 352B
+0.39%+2.22%+17.02%+23.87% 264B
+0.17%+2.19%+6.33%+10.93% 253B
+0.19%-3.81%+37.81%+43.02% 203B
-1.20%-6.64%-23.23%-59.10% 188B
+0.94%+1.39%+33.21%+95.29% 181B
Average -0.01%-1.99%+22.56%+34.81% 356.53B
Weighted average by Cap. -0.09%+0.01%+34.17%+59.59%

Financials

2026 *2027 *
Net sales 452M 391M 370M 336M 630M 43.34B 633M 4.42B 1.71B 21.98B 1.7B 1.66B 70.06B 489M 424M 401M 364M 682M 46.93B 686M 4.78B 1.85B 23.8B 1.84B 1.8B 75.87B
Net income -1.67M -1.45M -1.37M -1.24M -2.33M -160M -2.34M -16.31M -6.3M -81.18M -6.27M -6.13M -259M -19.7M -17.07M -16.13M -14.65M -27.45M -1.89B -27.61M -193M -74.42M -958M -73.98M -72.34M -3.05B
Net Debt -260M -226M -213M -194M -363M -24.97B -365M -2.55B -984M -12.67B -978M -956M -40.37B -326M -283M -267M -243M -455M -31.32B -458M -3.19B -1.23B -15.89B -1.23B -1.2B -50.64B
Logo Immunocore Holdings plc
Immunocore Holdings plc is a United Kingdom-based commercial-stage biotechnology company. The Company is engaged in the development of TCR bispecific immunotherapies, ImmTAX, which immunes mobilizing monoclonal TCRs against X disease, designed to treat a range of diseases, including cancer, autoimmune and infectious disease. The Company has a pipeline of clinical-stage programs in oncology and infectious diseases, as well as numerous pre-clinical projects. Its lead product, KIMMTRAK, is a TCR therapeutic for the treatment of patients with unresectable or metastatic uveal melanoma (mUM), in the United States, European Union, Canada, Australia and the United Kingdom. Its pipeline products include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-M113V, IMC-I109V, IMC-S118AI, and IMC-U120AI, among others. Its clinical programs are being conducted with patients with a range of cancers including melanoma, ovarian, lung, colorectal and others.
Employees
524
Date Price Change Volume
26-09-16 US$31.59 -0.58% 460,264
26-09-15 US$31.78 -2.11% 653,905
26-09-14 US$32.46 -0.43% 318,385
26-09-11 US$32.60 -2.92% 313,504
26-09-10 US$33.58 -2.58% 237,137
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
31.78USD
Average target price
62.50USD
Spread / Average Target
+96.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IMCR Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!